The scientists at BSRC “Alexander Fleming” perform cutting-edge research, aiming to understand molecular mechanisms of complex biological processes in health and disease. We are also committed to contribute to innovation in medicine, by developing novel therapeutic and diagnostic methods, focusing on immunity and inflammation, cancer, and neurodegenerative diseases. To keep our focus on top-notch research, we recruit at all levels with excellence as the sole criterion and we support our researchers by providing state-of-the science infrastructures and a pleasant working environment. FLEMING is a non-profit organization operating under the auspices of the Greek General Secretariat for Research & Technology and is supported by the Greek government and by national, European and international grants.


27 November 2019

A new Frontiers E-book on “Pulmonary Fibrosis”, guest-edited by Fleming Researchers and distinguished leading experts, was recently published. The E-book comprises of 13 peer-reviewed articles published in the corresponding research topic, in the section of Pulmonary Medicine, Frontiers in Medicine [Frontiers].

15 November 2019

Fleming researchers, in collaboration with GlaxoSmithKline and the London School of Hygiene and Tropical Medicine, developed a novel series of fast-kill agents against malaria. Chemoproteomic analysis also showed that the mechanism through which this fast-kill effect is exhibited is the inhibition of serine/arginine protein kinase 2 (SRPK2), thus rendering this target a tractable approach for developing antimalarial compounds with extremely fast-killing properties. [Pubmed]

06 November 2019

Glentis et al., from the Dimas lab, uncover genetic risk variants for hereditary breast cancer in the first exome sequencing study to be conducted in the Greek population. The authors carried out exome sequencing on BSRC Alexander Fleming’s in-house NGS platform, in patients with hereditary breast cancer of unknown genetic aetiology and in their informative relatives. [Pubmed]

29 October 2019

Custom bioinformatics analysis performed by Dr. Martin Reczko contributed to a new collaborative study that introduces a platform for bacterial production and direct functional screening of expanded molecular libraries for discovering inhibitors of protein aggregation, associated with a wide range of human disorders, including Alzheimer’s and Parkinson’s disease. [Science Advances]



Seminar 20/12/2019, 14.00. "At the crossroads of aging, metabolism and cognition", Lida Katsimbardi, PhD , Perception and Memory Lab, Neuroscience Dept., Institut Pasteur, Paris, France.


Visit BSRC Fleming's scientific Publications web page


Visit BSRC Fleming's funding web page


For internal users


For internal users

B.S.R.C. "Alexander Fleming"
34 Fleming Street, 16672 Vari, Greece
Contact us - Privacy Policy